Alexandra Collingbourne Alexandra Collingbourne

Arecor wins £2.8m from Innovate UK to boost fight against diabetes

Cambridge biopharma business Arecor has been awarded a £2.8 million grant from Innovate UK to support the Phase II development of AT247, an ultra-rapid acting insulin product candidate based on Arecor’s proprietary Arestat technology platform.

Read More
Alexandra Collingbourne Alexandra Collingbourne

Psyomics pilots digital mental health assessment Censeo

UK healthtech firm Psyomics has begun pilots of its mental health assessment platform Censeo in two London GP practices, gathering real-world data and feedback before commercial launch later this year.

Read More
Alexandra Collingbourne Alexandra Collingbourne

Axol Bioscience and Censo Biotechnologies announce merger

Axol Bioscience Ltd, an established provider of iPSC-derived cells, media, and characterisation services, and CENSO Biotechnologies, a cell biology CRO with focused expertise in iPSC-related technologies, today announced that the two companies have signed a merger agreement.

Read More
Alexandra Collingbourne Alexandra Collingbourne

Could a new treatment for diabetic eye disease be on the horizon?

Academics from the University of Bristol have contributed to the development of a potential treatment for Diabetic Macular Oedema (DMO); an eye condition affecting more than 20 million diabetes patients. This potentially game-changing drug has now reached the clinical trial stage and will be tested on 48 patient volunteers.

Read More
Alexandra Collingbourne Alexandra Collingbourne

Sorex Sensors founder honoured in Nova 111 global talent list

Dr Mario de Miguel Ramos, founder and CEO of University of Cambridge spin-out Sorex Sensors, has been named in the Nova 111 global talent list – which aims to recognise the “brightest stars” under 35. He features in the tech category of the list for his home country of Spain.

Read More